2026 NPPES data Primary Care Nurse Practitioner NPI 1669046843 AGNP
Verify on CMS →

PAULA ALLORO-LICHTENSTEIN, AGNP

Primary Care Nurse Practitioner in PLEASANTON, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
912
Medicare Part D claims · 115 beneficiaries · Primary Care Nurse Practitioner avg: 1K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

PAULA ALLORO-LICHTENSTEIN, AGNP filed 912 Medicare Part D claims in 2023 as a Primary Care Nurse Practitioner in PLEASANTON, California, prescribing 92% generic.

912
Part D claims, 2023
92%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PAULA ALLORO-LICHTENSTEIN, AGNP's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

912 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about PAULA ALLORO-LICHTENSTEIN, AGNP?

Quality data not reported

NPI registry status

Active

Issued 05/13/2021

NPI 1669046843

Primary specialty

Primary Care Nurse Practitioner

Mid-sized

10,138 US NPIs in this specialty

Medicare Part D claims

912 33% vs specialty avg

2023 prescription claims

Specialty avg: 1,363

Specialty distribution in California

How Primary Care Nurse Practitioner compares to other specialties among California providers

California providers

Primary Care Nurse Practitioner share within California

1. Primary Care Nurse Practitioner42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Primary Care Nurse Practitioner share within California

Specialty board-certification context

Estimated specialty board-certified rate — Primary Care Nurse Practitioner (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Primary Care Nurse Practitioner ABMS/AOA estimate

Est. board-certified rate (Primary Care Nurse Practitioner) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Primary Care Nurse Practitioner) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PAULA ALLORO-LICHTENSTEIN, AGNP appears in the CMS NPPES registry as a Primary Care Nurse Practitioner provider holding AGNP credentials at 5820 STONERIDGE MALL RD STE 209, PLEASANTON, CA, 94588, with a listed phone of (510) 573-4404. NPI 1669046843 was issued on 05/13/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALLORO-LICHTENSTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 912 prescription claims written by this provider, covering 115 Medicare beneficiaries and totaling roughly $44K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 2.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Primary Care Nurse Practitioner is a mid-sized specialty nationwide, with 10,138 enrolled providers across 54 states and an average of 1,363 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5820 STONERIDGE MALL RD STE 209
PLEASANTON, CA 94588

Provider Details

NPI 1669046843
Specialty Primary Care Nurse Practitioner
Credentials AGNP
Gender Female
NPI Issued 05/13/2021

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to PAULA ALLORO-LICHTENSTEIN, AGNP. To verify PAULA ALLORO-LICHTENSTEIN, AGNP's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

PAULA ALLORO-LICHTENSTEIN, AGNP — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 912 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

912
Total Claims
$44K
Total Drug Cost
115
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,747
Total Day Supply
49,418
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$18K
Generic Drug Cost
$25K
Opioid Claims
26 (2.9% rate)
Antibiotic Claims
46

Patient Demographics

Average Patient Age
86.5 years
Avg HCC Risk Score
2.24
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PAULA ALLORO-LICHTENSTEIN, AGNP prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Furosemide
54
Quetiapine Fumarate
45
Atorvastatin Calcium
41
Trazodone Hcl
40
Duloxetine Hcl
33
Gabapentin
27
Famotidine
26
Amlodipine Besylate
25
Lactulose
25
Metformin Hcl
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Primary Care Nurse Practitioner Overview

How PAULA ALLORO-LICHTENSTEIN, AGNP fits within the Primary Care Nurse Practitioner landscape nationally.

10,138
Primary Care Nurse Practitioner Providers in US
54
States with Primary Care Nurse Practitioner
1,363
Avg Claims per Provider

PAULA ALLORO-LICHTENSTEIN, AGNP's 912 claims are below the specialty average of 1,363.

Nearby Primary Care Nurse Practitioner Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ALLORO-LICHTENSTEIN.

Compare Primary Care Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is PAULA ALLORO-LICHTENSTEIN, AGNP's specialty?
PAULA ALLORO-LICHTENSTEIN, AGNP specializes in Primary Care Nurse Practitioner and practices in PLEASANTON, California. Credentials: AGNP.
How much does PAULA ALLORO-LICHTENSTEIN, AGNP prescribe under Medicare Part D?
In 2023, PAULA ALLORO-LICHTENSTEIN, AGNP wrote 912 Medicare Part D claims totaling $44K in drug costs for 115 beneficiaries.
Where is PAULA ALLORO-LICHTENSTEIN, AGNP located?
PAULA ALLORO-LICHTENSTEIN, AGNP is located at 5820 STONERIDGE MALL RD STE 209, PLEASANTON, CA, 94588. Phone: (510) 573-4404.
What is PAULA ALLORO-LICHTENSTEIN, AGNP's NPI number?
PAULA ALLORO-LICHTENSTEIN, AGNP's National Provider Identifier (NPI) is 1669046843, issued on 05/13/2021.
Does PAULA ALLORO-LICHTENSTEIN, AGNP prescribe more brand-name or generic drugs?
PAULA ALLORO-LICHTENSTEIN, AGNP's prescribing is 8% brand-name and 92% generic drugs by claim count, with $18K in brand drug costs.
Does PAULA ALLORO-LICHTENSTEIN, AGNP prescribe opioids?
Yes, PAULA ALLORO-LICHTENSTEIN, AGNP had 26 opioid claims in 2023 with an opioid prescribing rate of 2.9%.
How many Primary Care Nurse Practitioner providers are there in the US?
There are 10,138 Primary Care Nurse Practitioner providers across 54 states in the US. The average Primary Care Nurse Practitioner provider writes 1,363 Medicare Part D claims per year.
What drugs does PAULA ALLORO-LICHTENSTEIN, AGNP prescribe most often?
Based on 2023 Medicare Part D data, PAULA ALLORO-LICHTENSTEIN, AGNP's most frequently prescribed drugs include Furosemide, Quetiapine Fumarate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PAULA ALLORO-LICHTENSTEIN, AGNP accept Medicare?
PAULA ALLORO-LICHTENSTEIN, AGNP appears in CMS Medicare data with 912 Part D claims and 115 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PAULA ALLORO-LICHTENSTEIN, AGNP's credentials?
PAULA ALLORO-LICHTENSTEIN, AGNP's NPI is 1669046843 with credentials AGNP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology